At the top 36 mg dose, average weight loss was about 11.2% against 2.1% on placebo
Retatrutide is also administered via injection, usually weekly, but dosing protocols are still being refined in trials
The compounded tirzepatide with B12 formulation is distinct from the tirzepatide glycine blend and the tirzepatide niacinamide formulation, though all three are compounded preparations
Common side effects of retatrutide Retatrutide shares the same GI side effect profile as tirzepatide but at higher rates
Long-term safety and efficacy of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week open-label, multicenter, post-marketing clinical study
Race, ethnicity, age, treatment type, and functional status were associated with submission in the multivariable analysis